Key Highlights

  • CORZ shares rose 3.66% pre-market to $21.50, following a prior session close of $20.74 that itself fell 8.84%.
  • Core Scientific and AMD announced a partnership covering more than 500 megawatts of infrastructure beginning in 2027, with the potential to scale to 2.5 gigawatts.
  • The deal includes collaboration on AMD Instinct GPUs, EPYC CPUs and ROCm software deployment, along with market-priced warrants for AMD to purchase Core Scientific common stock.
  • The pre-market gain follows a downgrade from Keefe, Bruyette and Woods, which cut the stock to Market Perform from Outperform and lowered its price target to $25 from $28.
  • Core Scientific carries a market capitalization of approximately $6.59 billion and reported a trailing loss per share of $1.85.

New AMD Partnership Offsets Recent Downgrade

Core Scientific (NASDAQ:CORZ) shares rose nearly 4 percent in pre-market trading after the company announced a new partnership with AMD (NASDAQ:AMD) to support the deployment of AI infrastructure. Under the agreement, AMD will secure more than 500 megawatts of United States data center capacity beginning in 2027, with the opportunity to scale up to 2.5 gigawatts, to support end customer deployments of AMD's AI hardware and software solutions.

Core Scientific is a Dover, Delaware-based company that designs, builds and operates large-scale, purpose-built data centers for high-density colocation services. The company operates through three segments, including colocation and digital asset self-mining and hosted mining, and has increasingly pivoted its business toward serving artificial intelligence and high-performance computing workloads rather than its original focus on bitcoin mining.

As part of the agreement, Core Scientific and AMD will collaborate on physical infrastructure design and the deployment of AMD Instinct GPUs, EPYC CPUs and ROCm software across the expanded footprint. AMD will also receive market-priced warrants to purchase Core Scientific common stock, subject to certain commercial conditions, reinforcing the strategic nature of the relationship between the two companies.

Deal Comes Amid Analyst Skepticism on Leasing Pace

The rally partially offsets a sharp decline in the prior session, when shares fell nearly 9 percent after Keefe, Bruyette and Woods downgraded the stock to Market Perform from Outperform and cut its price target to $25 from $28. The research firm's downgrade cited elevated execution risk and pointed to a lengthy stretch without a new colocation lease signing for the company's AI infrastructure business, even as the firm said broader demand for high-performance computing colocation capacity remains robust across the sector.

Core Scientific carries a market capitalization of approximately $6.59 billion and trades without a positive trailing price-to-earnings ratio, reflecting a reported loss per share of $1.85. Shares have traded in a 52-week range of $12.60 to $30.46. The new AMD partnership, alongside the company's existing colocation customer relationships, will likely factor into how analysts reassess the pace of the company's infrastructure buildout in coming quarters.

Conclusion

Core Scientific's pre-market gain reflects investor optimism that the new AMD partnership can help address the leasing execution concerns raised in Monday's analyst downgrade. With the deal's capacity scaling gradually starting in 2027, the durability of Monday's rally will likely depend on how quickly the company can translate the agreement into signed, revenue-generating contracts.

This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research before making financial decisions.